Rossari Biotech board to meet for Q2 and H1 financial results approval

Rossari Biotech Limited announced on October 7, 2025, that its board of directors will meet on Wednesday, October 15, 2025. The primary agenda for this meeting is to consider and approve the unaudited financial results, encompassing both standalone and consolidated figures, for the quarter and half-year that concluded on September 30, 2025.

In accordance with its Code of Conduct for Prevention of Insider Trading, Rossari Biotech has closed its "Trading Window" for all "Designated Persons and their immediate relatives." This closure commenced on October 1, 2025, and will remain in effect for 48 hours following the public announcement of the unaudited financial results.

This important intimation is publicly accessible on the company's website at www.rossari.com. The company has requested that this information be duly recorded and disseminated to all relevant stakeholders.